Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7TQQ

Structure of human TREX1-DNA complex

Summary for 7TQQ
Entry DOI10.2210/pdb7tqq/pdb
DescriptorThree-prime repair exonuclease 1, DNA (5'-D(P*TP*TP*GP*GP*CP*CP*GP*GP*CP*CP*AP*TP*C)-3') (3 entities in total)
Functional Keywordsnuclease, dnase, innate immunity, autoimmunity, hydrolase, hydrolase-dna complex, hydrolase/dna
Biological sourceHomo sapiens (human)
More
Total number of polymer chains8
Total formula weight131113.20
Authors
Zhou, W.,Richmond-Buccola, D.,Kranzusch, P.J. (deposition date: 2022-01-26, release date: 2022-08-03, Last modification date: 2023-10-18)
Primary citationZhou, W.,Richmond-Buccola, D.,Wang, Q.,Kranzusch, P.J.
Structural basis of human TREX1 DNA degradation and autoimmune disease.
Nat Commun, 13:4277-4277, 2022
Cited by
PubMed Abstract: TREX1 is a cytosolic DNA nuclease essential for regulation of cGAS-STING immune signaling. Existing structures of mouse TREX1 establish a mechanism of DNA degradation and provide a key model to explain autoimmune disease, but these structures incompletely explain human disease-associated mutations and have limited ability to guide development of small-molecule therapeutics. Here we determine crystal structures of human TREX1 in apo and DNA-bound conformations that provide high-resolution detail of all human-specific features. A 1.25 Å structure of human TREX1 establishes a complete model of solvation of the exonuclease active site and a 2.2 Å structure of the human TREX1-DNA complex enables identification of specific substitutions involved in DNA recognition. We map each TREX1 mutation associated with autoimmune disease and establish distinct categories of substitutions predicted to impact enzymatic function, protein stability, and interaction with cGAS-DNA liquid droplets. Our results explain how human-specific substitutions regulate TREX1 function and provide a foundation for structure-guided design of TREX1 therapeutics.
PubMed: 35879334
DOI: 10.1038/s41467-022-32055-z
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

250059

PDB entries from 2026-03-04

PDB statisticsPDBj update infoContact PDBjnumon